Saltar al contenido
Merck

The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.

Cell research (2015-11-28)
Carsten Gram Hansen, Yuen Lam Dora Ng, Wai-Ling Macrina Lam, Steven W Plouffe, Kun-Liang Guan
RESUMEN

YAP and TAZ are transcriptional co-activators and function as the major effectors of the Hippo tumor suppressor pathway, which controls cell growth, tissue homeostasis, and organ size. Here we show that YAP/TAZ play an essential role in amino acid-induced mTORC1 activation, particularly under nutrient-limiting conditions. Mechanistically, YAP/TAZ act via the TEAD transcription factors to induce expression of the high-affinity leucine transporter LAT1, which is a heterodimeric complex of SLC7A5 and SLC3A2. Deletion of YAP/TAZ abolishes expression of LAT1 and reduces leucine uptake. Re-expression of SLC7A5 in YAP/TAZ knockout cells restores leucine uptake and mTORC1 activation. Moreover, SLC7A5 knockout cells phenocopies YAP/TAZ knockout cells which exhibit defective mTORC1 activation in response to amino acids. We further demonstrate that YAP/TAZ act through SLC7A5 to provide cells with a competitive growth advantage. Our study provides molecular insight into the mechanism of YAP/TAZ target genes in cell growth regulation.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Fibronectina plasma bovino, solution, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Piruvato sódico, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99%
Sigma-Aldrich
Tetracycline, 98.0-102.0% (HPLC)
Sigma-Aldrich
Tetracycline, 98.0-102.0% (HPLC)
Sigma-Aldrich
Piruvato sódico, Hybri-Max, powder, suitable for hybridoma
Sigma-Aldrich
Piruvato sódico, powder, BioXtra, suitable for mouse embryo cell culture
Sigma-Aldrich
Piruvato sódico, ReagentPlus®, ≥99%
Sigma-Aldrich
Piruvato sódico, BioXtra, ≥99%
Sigma-Aldrich
Piruvato sódico, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%
Sigma-Aldrich
MISSION® esiRNA, targeting human SLC7A5